The blurring boundaries between placental and maternal preeclampsia: a critical appraisal of 1800 consecutive preeclamptic cases

Abstract Objectives To present a comprehensive overview of different risk factors for early onset preeclampsia (<34 weeks gestation, EOP) vs. late onset (LOP). Study design South-Reunion University’s maternity (Reunion Island, Indian Ocean). 18.5 year-observational population-based cohort study (2001–2019). Epidemiological perinatal database with information on obstetrical and neonatal risk factors. All consecutive singleton pregnancies (>21 weeks) compared with all preeclamptic pregnancies delivered in the south of Reunion island. Main outcome measures Comparing risk factors between EOP and LOP. Results Among 1814 singleton preeclamptic pregnancies (600 EOP and 1214 LOP), EOP women were older than LOP 29.5 vs. 28.6 years, p = .009, primigravidas (OR 0.78 [0.63–0.96], p = .02) were prone to LOP. History of preeclampsia (PE) (aOR 12.8 vs. 7.1), chronic hypertension (aOR 6.5 vs. 4.5) had much higher adjusted odds ratios for EOP than for LOP, p < .001. Specific to EOP: coagulopathies (aOR 2.95, p = .04), stimulated pregnancies (aOR 3.9, p = .02). Specific to LOP: renal diseases (aOR 2.0, p = .05) and protective effect for smoking (aOR 0.75, p = .008). EOP women were prone to have a lower BMI. Conclusion “Placental preeclampsia” (defective placentation) being linked to early onset PE (<34 weeks gestation) while “maternal preeclampsia” (maternal cardiovascular predisposition) being typically manifesting as the late form of the disease LOP is not systematically verified. Future researches are needed to propose a more adapted paradigm. Highlights   Risk factors for different preeclampsia phenotypes (early/late); challenging proposed models

[1]  T. Hulsey,et al.  Increased BMI has a linear association with late-onset preeclampsia: A population-based study , 2019, PloS one.

[2]  M. Boukerrou,et al.  Incidence and natural history of preeclampsia/eclampsia at the university maternity of Antananarivo, Madagascar: high prevalence of the early-onset condition , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[3]  W. Gyselaers,et al.  Preeclampsia: a gestational cardiorenal syndrome , 2019, The Journal of physiology.

[4]  G. Burton,et al.  Pre-eclampsia: pathophysiology and clinical implications , 2019, BMJ.

[5]  A. Staff The two-stage placental model of preeclampsia: An update. , 2019, Journal of reproductive immunology.

[6]  M. Faas,et al.  Memory T Cells in Pregnancy , 2019, Front. Immunol..

[7]  A. Maged,et al.  Maternal, fetal, and neonatal outcomes among different types of hypertensive disorders associating pregnancy needing intensive care management , 2018, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[8]  L. Magee,et al.  Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. , 2018, Hypertension.

[9]  L. Magee,et al.  The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. , 2018, Pregnancy hypertension.

[10]  D. Kell,et al.  Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father , 2017, bioRxiv.

[11]  P. Robillard,et al.  Comparison of risk factors and perinatal outcomes in early onset and late onset preeclampsia: A cohort based study in Reunion Island. , 2017, Journal of reproductive immunology.

[12]  E. Ekholm,et al.  Eclampsia in Finland; 2006 to 2010 , 2016, Acta obstetricia et gynecologica Scandinavica.

[13]  A. Park,et al.  Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies , 2016, British Medical Journal.

[14]  I. Sargent,et al.  IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia? , 2014, Placenta.

[15]  K. Joseph,et al.  Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. , 2013, American journal of obstetrics and gynecology.

[16]  T. Hulsey,et al.  Etiology of preeclampsia: maternal vascular predisposition and couple disease--mutual exclusion or complementarity? , 2007, Journal of reproductive immunology.

[17]  I. Sargent,et al.  Preeclampsia: an excessive maternal inflammatory response to pregnancy. , 1999, American journal of obstetrics and gynecology.

[18]  R. Ness,et al.  Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. , 1996, American journal of obstetrics and gynecology.

[19]  J. D. Vries,et al.  Underlying disorders associated with severe early-onset preeclampsia. , 1995, American journal of obstetrics and gynecology.

[20]  C. Redman Pre-eclampsia and the placenta , 1991 .

[21]  T. Hulsey,et al.  Validation of the 34-week gestation as definition of late onset preeclampsia: Testing different cutoffs from 30 to 37 weeks on a population-based cohort of 1700 preeclamptics , 2020 .

[22]  B. Sibai,et al.  The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). , 2013, Pregnancy hypertension.

[23]  J. P. Peña-Rosas,et al.  WHO recommendations for Prevention and treatment of pre-eclampsia and eclampsia , 2011 .

[24]  C. Redman Current topic: pre-eclampsia and the placenta. , 1991, Placenta.